Blood‑based biomarkers are reshaping Alzheimer’s trials by enabling earlier, cheaper identification. Could these enrolment strategies translate to other slow‑progressing diseases? ICON experts share their insight in the ...

For global clinical trials, localisation, translation availability and linguistic validation can all affect when and how a clinical outcome assessment can be implemented across countries. Yet these considerations are o...

We're heading to Boston for The MedTech Conference, 18 – 21 October. Whether you're developing a medical device, diagnostic, digital health technology, wearable, or combination product, successful development requires m...

Great teams are built through shared experiences. Our Beijing colleagues recently stepped away from their desks to enjoy a day of team-building activities followed by a group dinner. The event provided a fantastic oppor...

ICON is proud to be the Platinum Sponsor of the TOPRA Symposium 2026, Europe’s premier conference for healthcare regulatory affairs. Taking place at the Royal Jaarbeurs in Utrecht from 19 to 21 October, the Symposium wi...

Eligibility criteria that successfully identify high-risk patients in a clinical trial may be impossible to replicate in routine practice. For MASLD developers, regulatory success and commercial viability are not the sam...

The pressure to make confident development decisions earlier has never been greater. Discover how innovative early phase trial designs, patient engagement strategies, and biomarker insights are helping sponsors navigate ...

Earlier this week, employees in Chengdu celebrated the opening of their new workspace, created to support the continued growth of the local team and future business needs. The larger office increases capacity and provide...

Regulatory requirements continue to evolve across global markets. Keeping pace with changes from the FDA, EMA, MHRA, PMDA, NMPA and other health authorities is critical for successful product development and lifecycle ma...

Strong teams aren't built in meeting rooms alone. More than 60 colleagues from our Dalian office in China recently stepped away from their desks to enjoy a day focused on collaboration, connection, and shared experience...

Continuous biomarkers offer a powerful opportunity to improve patient selection, yet defining the right cut-off remains a major challenge across diverse populations. Discover how developers are navigating these methodolo...

The fourth and final article in MedTech Insight’s PPWR series examines how medical device manufacturers can minimise packaging without compromising product protection, sterility or regulatory compliance. ICON regulatory...